메뉴 건너뛰기




Volumn 29, Issue 8, 2007, Pages 1063-1066

Acute renal failure after initiation of tenofovir disoproxil fumarate

Author keywords

Acute renal failure; HIV; Tenofovir

Indexed keywords

COTRIMOXAZOLE; CREATININE; EFAVIRENZ; EFAVIRENZ PLUS EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; PARACETAMOL; TENOFOVIR DISOPROXIL;

EID: 36849001430     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220701643831     Document Type: Article
Times cited : (6)

References (16)
  • 1
    • 1642453729 scopus 로고    scopus 로고
    • Tenofovir disoproxil fumarate in nucleoside-resistant HIV-1 infection
    • Squires K, Pozniak AL, Pierone G, et al. (2003). Tenofovir disoproxil fumarate in nucleoside-resistant HIV-1 infection. Ann Intern Med. 2003;139:313-320.
    • (2003) Ann Intern Med , vol.2003 , Issue.139 , pp. 313-320
    • Squires, K.1    Pozniak, A.L.2    Pierone, G.3
  • 2
    • 3042848853 scopus 로고    scopus 로고
    • Efficacy and safety of tenofovir DF vs. stavudine in combination therapy in antiretroviral- naïve patients: A three-year randomized trial
    • Gallant JE, Staszeweski S, Pozniak AL, et al. (2004). Efficacy and safety of tenofovir DF vs. stavudine in combination therapy in antiretroviral- naïve patients: A three-year randomized trial. JAMA. 2004;292:191-201.
    • (2004) JAMA , vol.2004 , Issue.292 , pp. 191-201
    • Gallant, J.E.1    Staszeweski, S.2    Pozniak, A.L.3
  • 3
    • 30944468562 scopus 로고    scopus 로고
    • Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV
    • Gallant JE, DeJesus E, Arribas JR, et al. Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV. N Engl J Med. 2006;354:251-260.
    • (2006) N Engl J Med , vol.354 , pp. 251-260
    • Gallant, J.E.1    DeJesus, E.2    Arribas, J.R.3
  • 4
    • 0038178864 scopus 로고    scopus 로고
    • Drug-induced renal failure: Update on new medications and unique mechanisms of nephrotoxicity
    • Perazella MA. Drug-induced renal failure: Update on new medications and unique mechanisms of nephrotoxicity. Am J Med Sci. 2003;325(6):349-362.
    • (2003) Am J Med Sci , vol.325 , Issue.6 , pp. 349-362
    • Perazella, M.A.1
  • 5
    • 33846420624 scopus 로고    scopus 로고
    • Functional involvement of multidrug-resistance-associated protein 4 (MRP4/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir
    • Imoka A, Kusuhara H, Adachi M, et al. (2007). Functional involvement of multidrug-resistance-associated protein 4 (MRP4/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir. Mol Pharmacol. 2007;71:619-627.
    • (2007) Mol Pharmacol , vol.2007 , Issue.71 , pp. 619-627
    • Imoka, A.1    Kusuhara, H.2    Adachi, M.3
  • 6
    • 0037447180 scopus 로고    scopus 로고
    • Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: Three cases of renal failure, Fanconi Syndrome, and nephrogenic diabetes insipdus
    • Karras A, Lafaurie M, Furco A, et al. Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: Three cases of renal failure, Fanconi Syndrome, and nephrogenic diabetes insipdus. Clin Infect Dis. 2003;36:1070-1073.
    • (2003) Clin Infect Dis , vol.36 , pp. 1070-1073
    • Karras, A.1    Lafaurie, M.2    Furco, A.3
  • 7
    • 16844370820 scopus 로고    scopus 로고
    • Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment
    • Gallant JE, Parish MA, Keruly JC, Moore RD. Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment. Clin Infect Dis. 2005;40:1194-1198.
    • (2005) Clin Infect Dis , vol.40 , pp. 1194-1198
    • Gallant, J.E.1    Parish, M.A.2    Keruly, J.C.3    Moore, R.D.4
  • 8
    • 0036953640 scopus 로고    scopus 로고
    • Acute renal failure associated with tenofovir: Evidence of drug-induced nephrotoxicity
    • Coca S, Perazella MA. Acute renal failure associated with tenofovir: Evidence of drug-induced nephrotoxicity. Am J Med Sci. 2002;324(6): 342-344.
    • (2002) Am J Med Sci , vol.324 , Issue.6 , pp. 342-344
    • Coca, S.1    Perazella, M.A.2
  • 10
    • 33749531758 scopus 로고    scopus 로고
    • Mechanism of acute renal tubular efflux of tenofovir
    • Ray SA, Cihlar T, Robinson KL, et al. Mechanism of acute renal tubular efflux of tenofovir. Anitmicrob. Agents Chemother. 2006;50(10):3297-3304.
    • (2006) Anitmicrob. Agents Chemother , vol.50 , Issue.10 , pp. 3297-3304
    • Ray, S.A.1    Cihlar, T.2    Robinson, K.L.3
  • 11
    • 34247528947 scopus 로고    scopus 로고
    • Unlikely association of multidrug-resistance protein-2 single-nucleotide polymorphisms with tenofovir-induced renal adverse events
    • Ray AS, Cihlar T. Unlikely association of multidrug-resistance protein-2 single-nucleotide polymorphisms with tenofovir-induced renal adverse events. CID. 2007;195:1389.
    • (2007) CID , vol.195 , pp. 1389
    • Ray, A.S.1    Cihlar, T.2
  • 12
    • 36849050513 scopus 로고    scopus 로고
    • Role of intestinal absorption in increased tenofovir exposure when tenofovir disoproxil fumarate is co-administered with atazanavir or lopinavir/ritonavir
    • Abstract, Lisbon;
    • Ray AS, et al. Role of intestinal absorption in increased tenofovir exposure when tenofovir disoproxil fumarate is co-administered with atazanavir or lopinavir/ritonavir. HIV Pharmacology Workshop. Abstract #49. Lisbon; 2006.
    • (2006) HIV Pharmacology Workshop , Issue.49
    • Ray, A.S.1
  • 14
    • 33845226137 scopus 로고    scopus 로고
    • Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathy
    • Izzedine H, Hulot JS, Villard E, et al. Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathy. JID. 2006;194:1481-1491.
    • (2006) JID , vol.194 , pp. 1481-1491
    • Izzedine, H.1    Hulot, J.S.2    Villard, E.3
  • 15
    • 10044236429 scopus 로고    scopus 로고
    • Renal dysfunction with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy regimens is not observed more frequently
    • Jones R, Stebbing J, Nelson M, et al. Renal dysfunction with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy regimens is not observed more frequently. J Acquir Immune Defic Syndr. 2004;37:1489-1495.
    • (2004) J Acquir Immune Defic Syndr , vol.37 , pp. 1489-1495
    • Jones, R.1    Stebbing, J.2    Nelson, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.